Haha. There is nothing they can fo but wait for FDA aproval for in human trials... Prob not far away now. Standard issue with biotechs. One thing they have not done is dilute shareholders with unnecessarily large raises like most. They just grab enough funds to keep going..very commendable.
Once human trials start this will fly!
Sounds like biotechs/long term investments maybe are not for you...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.005(1.43%) |
Mkt cap ! $99.76M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.5¢ | 33.5¢ | $38.26K | 112.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 10016 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 8605 | 1 |
View Market Depth
| Last trade - 15.56pm 18/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |